Ark Invest Boosts SpaceX Stake with $52M Purchase Amid Portfolio Adjustments

Details on New Acquisitions and Reductions

The investment manager allocated substantial resources to SpaceX across multiple ETFs, which included ARKK, ARKQ, ARKW, and ARKX. Aside from SpaceX, Ark made new investments in companies including Eli Lilly, Meta Platforms, and X-Energy, among other tech and healthcare stocks. However, the firm also cut its stakes in notable companies such as AMD, Roku, and several genomics stocks like Natera and Illumina.

Continued Interest in SpaceX

Ark Invest’s latest trades continue a trend observed in recent weeks, where the firm has increasingly bolstered its position in SpaceX. Following a decline in stock prices post-IPO, Ark previously invested $32.5 million in SpaceX, which had dropped significantly from its peak. Earlier, the firm also made a landmark investment of $444.3 million during the company’s debut on the Nasdaq.

Ark’s Valuation Insights

Cathie Wood, the founder and CEO of Ark Invest, expressed confidence in SpaceX’s growth potential, claiming the company holds a 10-year lead over its competitors. Ark’s internal valuation models have projected a base-case enterprise value of approximately $2.5 trillion by 2030, with a bullish estimate placing it at around $3.1 trillion.

Looking Ahead

The adjustments made by Ark come just as the market prepares for the second-quarter earnings season, indicating a proactive approach to managing and rebalancing their portfolios in the current economic climate. As Ark continues to tweak its holdings, the firm remains focused on maintaining balanced exposure to various segments while identifying high-potential investments across evolving markets.